期刊文献+

玻璃酸钠和益赛普关节腔注射治疗类风湿关节炎临床报道 被引量:3

下载PDF
导出
摘要 目的探讨联合使用玻璃酸钠和益赛普关节腔注射治疗类风湿关节炎的疗效。方法 64例类风湿关节炎患者随机分为两组:联合组30例,采用玻璃酸钠2 ml和益赛普25 mg进行膝关节腔内注射,以后单独皮下注射益赛普;对照组34例,膝关节腔内注入益赛普,以后单独皮下注射益赛普。结果两组患者随访6个月,联合组总有效率为93.3%,对照组总有效率为73.5%,两组疗效比较差异有统计学意义(P<0.05)。结论玻璃酸钠和益赛普联用与单用益赛普治疗类风湿关节炎均有疗效,但前者疗效更佳。
出处 《中国实用医药》 2014年第32期115-116,共2页 China Practical Medicine
  • 相关文献

参考文献2

二级参考文献31

  • 1邓小虎,黄烽.英夫利西单抗治疗炎性关节病的研究进展[J].中国药物应用与监测,2006,3(6):10-14. 被引量:17
  • 2MAIN1 R, ST CLAIR EW, BREEDVELD F, et al. Infliximab (chimeric anti-tumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase Ⅲ trial [J]. Lancet, 1999,354(9194) :1932 - 1939.
  • 3ST CLAI EW, VAN DER HEIJDE D, SMOLEN J, et al. Combi- nation of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial [ J]. Arthritis Rheum, 2004,50(11 ) :3432 -3443.
  • 4MAINI RN, BREEDVELD FC, KALDEN JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis[ J]. Arthritis Rheum, 1998, 41(9) :1552 - 1563.
  • 5LANGE U, TEICHMANN J, MULLE LADNER U, et at. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-antibody: a prospective open-label pilot study [ J ]. Rheumatology, 2005, 44 ( 12 ) : 1546 - 1548.
  • 6TARGAN SR, HANAUER SB, VAN DEVENTER SJH. A shortterm study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Corhn's disease[JJ. N Engl J Med, 1997,337 (15) :1029 - 1035.
  • 7HANAUER SB, FEAGAN BG, LICHTENSTIN GR,et al. Maintenance infiliximab for Crohn's disease: the ACCENT I randomized trial[J]. Lancet, 2002,359(9317) :1541 -1549.
  • 8PRESENT DH, RUTGEERTS P, TARGAN S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease[ J]. N Engl J Med, 1999,340 ( 18 ) : 1398 - 1405.
  • 9BRAUN J, BRANDT J, LISTING J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial[ J ]. Lancet,2002,359 (9313 ) : 1187 - 1193.
  • 10VAN DEN BOSCH F, KRUITHOF E, BAETEN D, et al. Randomized double-bllnd comparison of chimeric monoclonal antibody to tumor necrosis factor alpha(infliximab) versus placebo in active spondylarthropathy [ J ]. Arthritis Rheum, 2002, 46 ( 3 ) : 755 -765.

共引文献22

同被引文献26

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部